{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "ATHX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents at beginning of year",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 51059000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 262000
            },
            {
                "label": "Prepaid expenses and other",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1791000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 57840000
            },
            {
                "label": "Equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3002000
            },
            {
                "label": "Deposits and other",
                "concept": "athx:DepositsAndOtherAssetsNonCurrent",
                "unit": "usd",
                "value": 888000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 61730000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 9163000
            },
            {
                "label": "Accrued compensation and related benefits",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1901000
            },
            {
                "label": "Accrued clinical trial related costs",
                "concept": "athx:AccruedClinicalTrialCostsCurrent",
                "unit": "usd",
                "value": 1276000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 461000
            },
            {
                "label": "Accrued license fee expense",
                "concept": "athx:AccruedLicenseFeesCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred revenue - Healios",
                "concept": "athx:ContractwithCustomerLiabilityDeferredRevenueCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 15475000
            },
            {
                "label": "Preferred stock, at stated value; 10,000,000 shares authorized, and no shares issued and outstanding at December 31, 2018 and 2017",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized; 144,292,739 and 122,077,453 shares issued and outstanding at December 31, 2018 and 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 144000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 416014000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -373042000
            },
            {
                "label": "Capitalization and Warrant Instruments",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 43116000
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 61730000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -24283000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 855000
            },
            {
                "label": "Gain from forgiveness of note payable",
                "concept": "athx:GainLossOnForgivenessOfNotePayable",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 3800000
            },
            {
                "label": "Discount on revenue from issuance of warrant",
                "concept": "athx:DiscountOnRevenueFromIssuanceOfWarrant",
                "unit": "usd",
                "value": 1080000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Stock\u2013based patent license and settlement expense",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 315000
            },
            {
                "label": "Gain from insurance proceeds, net",
                "concept": "GainOnBusinessInterruptionInsuranceRecovery",
                "unit": "usd",
                "value": 600000
            },
            {
                "label": "Change in fair value of warrant liabilities",
                "concept": "athx:FairValueAdjustmentOfWarrantsAndOther",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -324000
            },
            {
                "label": "Prepaid expenses and other",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 1346000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 4269000
            },
            {
                "label": "Advances and deposits from Healios",
                "concept": "athx:IncreaseDecreaseInContractWithCustomerLiabilityAdvancesAndDepositsFromCustomer",
                "unit": "usd",
                "value": 4889000
            },
            {
                "label": "Deferred revenue",
                "concept": "athx:IncreaseDecreaseInContractWithCustomerLiabilityDeferredRevenue",
                "unit": "usd",
                "value": -250000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -13350000
            },
            {
                "label": "Purchase of available-for-sale securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Sales of available-for-sale securities",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from insurance, net",
                "concept": "ProceedsFromInsuranceSettlementInvestingActivities",
                "unit": "usd",
                "value": 617000
            },
            {
                "label": "Purchases of equipment",
                "concept": "PaymentsToAcquireMachineryAndEquipment",
                "unit": "usd",
                "value": 1532000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -915000
            },
            {
                "label": "Proceeds from issuance of common stock, net",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 15415000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Shares retained for withholding tax payments on stock-based awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 402000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 36008000
            },
            {
                "label": "Increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 21743000
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 24291000
            },
            {
                "label": "Research and Development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 38656000
            },
            {
                "label": "General and Administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 10442000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 855000
            },
            {
                "label": "Total costs and expenses",
                "concept": "athx:CostsAndExpensesBeforeOther",
                "unit": "usd",
                "value": 49953000
            },
            {
                "label": "Gain from insurance proceeds, net",
                "concept": "GainOnBusinessInterruptionInsuranceRecovery",
                "unit": "usd",
                "value": 600000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -25045000
            },
            {
                "label": "Income (expense) from change in fair value of warrants, net",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 762000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -24283000
            },
            {
                "label": "Income tax benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net and comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -24283000
            },
            {
                "label": "Basic and diluted net loss per common share (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.18
            },
            {
                "label": "Weighted average shares outstanding, basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 136641000
            }
        ]
    }
}